EVOLUTION IN HIV/AIDS TREATMENT AND FUTURE DEVELOPMENT

pharmacy

HIV being life threatening infectious and cancerous, it is very difficult to understand, cure and stop infection completely. After the release of zidovudine and first anti-retroviral therapy (ART) in 1987, treatment of HIV has improved so much but still isn’t curable it can only be controlled. Over past 5 years, advancement in human immunodeficiency virus type 1 (HIV-1) clinical research and data on the effectiveness of potent combination therapy have substantially influenced the general perspective of the long-term management of HIV-1 disease. Moving on to evolution, anti-retroviral therapy its development, nitric oxide based anti-retroviral therapy and stem cell therapy have been proved a boost in the treatment and management of HIV/AIDS. On a continued research and development in the complete cure and management of HIV/AIDS drugs like Azvudin in phase III trial, drug in the way of development to target different stages of HIV life cycle like Isltravir and fostemsavir are under progress. In case of long acting anti-retroviral, cabotegravir LA and rilpivirine LA are under progress which can be a leading step to the development in the treatment of HI/AIDS.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.